Literature DB >> 884021

Vasodilator treatment for acute and chronic heart failure.

K Chatterjee, W W Parmley.   

Abstract

The current status of the use of vasodilator drugs in the treatment of acute and chronic heart failure has been reviewed. It is apparent that vasodilator treatment can be used effectively in some patients with heart failure with a beneficial haemodynamics response, and that vasodilator agents are likely to find an important place in the management of such patients. Vasodilator treatment may be associated with complications and must be used with care. Though several nonparenteral vasodilator agents have been investigated, no ideal drug is yet available for the treatment of chronic heart failure. Nevertheless, it is probable that suitable drugs will emerge and find an important place in the management of such patients.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 884021      PMCID: PMC483307          DOI: 10.1136/hrt.39.7.706

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  56 in total

1.  EFFECT OF CORONARY VASODILATOR DRUGS ON RETROGRADE FLOW IN AREAS OF CHRONIC MYOCARDIAL ISCHEMIA.

Authors:  W M FAM; M MCGREGOR
Journal:  Circ Res       Date:  1964-10       Impact factor: 17.367

2.  The local effect of glyceryl trinitrate, nitrite, papaverine, and atropine upon coronary vascular resistance.

Authors:  E D FROHLICH; J B SCOTT
Journal:  Am Heart J       Date:  1962-03       Impact factor: 4.749

3.  Effect of nitroglycerin on the coronary circulation in patients with coronary artery disease or increased left ventricular work.

Authors:  R GORLIN; N BRACHFELD; C MACLEOD; P BOPP
Journal:  Circulation       Date:  1959-05       Impact factor: 29.690

4.  Action of nitroglycerin on the coronary circulation in normal and in mild cardiac subjects.

Authors:  N BRACHFELD; J BOZER; R GORIN
Journal:  Circulation       Date:  1959-05       Impact factor: 29.690

5.  Hemodynamic effects of quantitatively varied experimental mitral regurgitation.

Authors:  E BRAUNWALD; G H WELCH; S J SARNOFF
Journal:  Circ Res       Date:  1957-09       Impact factor: 17.367

6.  Systemic and coronary hemodynamic effects of sodium nitroprusside.

Authors:  G G Rowe; R H Henderson
Journal:  Am Heart J       Date:  1974-01       Impact factor: 4.749

Review 7.  The role of vasodilator therapy in heart failure.

Authors:  K Chatterjee; W W Parmley
Journal:  Prog Cardiovasc Dis       Date:  1977 Jan-Feb       Impact factor: 8.194

8.  Hemodynamic and metabolic effects of sodium nitroprusside on the performance and metabolism of regional ischemic myocardium;.

Authors:  P L Luz; J S Forrester; H L Wyatt; J V Tyberg; R Chagrasulis; W W Parmley; H J Swan
Journal:  Circulation       Date:  1975-09       Impact factor: 29.690

9.  Oral hydralazine therapy for chronic refractory heart failure.

Authors:  K Chatterjee; W W Parmley; B Massie; B Greenberg; J Werner; S Klausner; A Norman
Journal:  Circulation       Date:  1976-12       Impact factor: 29.690

10.  Effect of alterations of arterial blood pressure and heart rate on segmental dyskinesis during acute myocardial ischemia and following coronary reperfusion.

Authors:  R E Kerber; F M Abboud
Journal:  Circ Res       Date:  1975-01       Impact factor: 17.367

View more
  20 in total

Review 1.  Modern treatment of heart failure.

Authors:  A D Timmis
Journal:  BMJ       Date:  1988-07-09

Review 2.  Cardiogenic shock.

Authors:  C E Handler
Journal:  Postgrad Med J       Date:  1985-08       Impact factor: 2.401

3.  Beneficial effects of captopril in left ventricular failure in patients with myocardial infarction.

Authors:  J P Bounhoure; J G Kayanakis; J M Fauvel; J Puel
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

4.  Circulatory effects of controlled arterial hypotension with trimetaphan (Arfonad). Experimental study in patients with left ventricular failure.

Authors:  S Nitter-Hauge
Journal:  Br Heart J       Date:  1978-04

5.  Hydrallazine alone in acute left ventricular failure.

Authors:  A J Clark; H B McMichael
Journal:  Postgrad Med J       Date:  1981-09       Impact factor: 2.401

6.  Cardiovascular effects of prenalterol on rest and exercise haemodynamics in patients with chronic congestive cardiac failure.

Authors:  A C Tweddel; R G Murray; D Pearson; W Martin; I Hutton
Journal:  Br Heart J       Date:  1982-04

7.  Salbutamol in cardiogenic shock complicating acute myocardial infarction.

Authors:  J R Dawson; P A Poole-Wilson; G C Sutton
Journal:  Br Heart J       Date:  1980-05

8.  Treatment of chronic heart failure with pirbuterol: acute haemodynamic responses.

Authors:  J R Dawson; R Canepa-Anson; P Kuan; N H Whitaker; J Carnie; C Warnes; S R Reuben; P A Poole-Wilson; G C Sutton
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-02

9.  [Treatment of severe congestive heart failure with the beta-agonist fenoterol (author's transl)].

Authors:  M Irmer; H Wollschläger; H Just
Journal:  Klin Wochenschr       Date:  1981-06-15

10.  Treatment of chronic heart failure with slow release phentolamine.

Authors:  A J Georgopoulos; A Valasidis; D Siourthas
Journal:  Eur J Clin Pharmacol       Date:  1978-07-30       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.